{"id":"dydrogesterone","rwe":[],"tags":[{"label":"dydrogesterone","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Progesterone receptor","category":"target"},{"label":"PGR","category":"gene"},{"label":"NR2E1","category":"gene"},{"label":"G03DB01","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Luteal phase support","category":"indication"},{"label":"Prevention of premature ovulation during controlled ovarian stimulation","category":"indication"},{"label":"Solvay","category":"company"},{"label":"Hormones","category":"pharmacology"},{"label":"Progestins","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":136.145,"date":"","count":23,"signal":"Ovarian hyperstimulation syndrome","source":"DrugCentral FAERS","actionTaken":"Reported 23 times (LLR=136)"},{"llr":98.61,"date":"","count":41,"signal":"Maternal exposure during pregnancy","source":"DrugCentral FAERS","actionTaken":"Reported 41 times (LLR=99)"},{"llr":87.467,"date":"","count":11,"signal":"Placenta accreta","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=87)"},{"llr":54.935,"date":"","count":8,"signal":"Pelvic infection","source":"DrugCentral FAERS","actionTaken":"Reported 8 times (LLR=55)"},{"llr":54.814,"date":"","count":25,"signal":"Exposure during pregnancy","source":"DrugCentral FAERS","actionTaken":"Reported 25 times (LLR=55)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Solvay","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=DYDROGESTERONE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:42:18.557080+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:42:24.479613+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DYDROGESTERONE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:42:24.828559+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Progesterone receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:42:25.891070+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200853/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:42:25.540581+00:00"}},"allNames":"gynorest","offLabel":[],"synonyms":["dydrogesterone","hydrogesterone","isopregnenone"],"timeline":[{"date":"1965-12-01","type":"positive","source":"DrugCentral","milestone":"PMDA approval"},{"date":"2000-01-01","type":"neutral","source":"FDA Orange Book","milestone":"Rights transferred from SOLVAY to Solvay"}],"approvals":[{"date":"1965-12-01","orphan":false,"company":"","regulator":"PMDA"},{"date":"","orphan":false,"company":"SOLVAY","regulator":"FDA"}],"brandName":"Gynorest","ecosystem":[{"indication":"Luteal phase support","otherDrugs":[],"globalPrevalence":null},{"indication":"Prevention of premature ovulation during controlled ovarian stimulation","otherDrugs":[{"name":"cetrorelix","slug":"cetrorelix","company":"Emd Serono Inc"},{"name":"medroxyprogesterone","slug":"medroxyprogesterone","company":"Pharmacia And Upjohn"}],"globalPrevalence":null}],"mechanism":{"target":"Progesterone receptor","novelty":"First-in-class","targets":[{"gene":"PGR","source":"DrugCentral","target":"Progesterone receptor","protein":"Progesterone receptor"},{"gene":"NR2E1","source":"DrugCentral","target":"Nuclear receptor subfamily 2 group E member 1","protein":"Nuclear receptor subfamily 2 group E member 1"}],"modality":"Small Molecule","drugClass":"dydrogesterone","explanation":"","oneSentence":"","technicalDetail":"Dydrogesterone is a synthetic progestogen that selectively binds to the progesterone receptor, exerting its effects through the regulation of gene expression and cellular signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/975","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=DYDROGESTERONE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DYDROGESTERONE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T10:54:58.932403","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:42:27.185883+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"megestrol acetate","drugSlug":"megestrol-acetate","fdaApproval":"1971-08-18","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"dienogest","drugSlug":"dienogest","fdaApproval":"2010-05-06","relationship":"same-class"}],"genericName":"dydrogesterone","indications":{"approved":[{"name":"Luteal phase support","source":"DrugCentral","snomedId":6738008,"regulator":"FDA"},{"name":"Prevention of premature ovulation during controlled ovarian stimulation","source":"DrugCentral","snomedId":732970000,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"currentOwner":"Solvay","drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"megestrol-acetate","brandName":"megestrol acetate","genericName":"megestrol acetate","approvalYear":"1971","relationship":"same-class"},{"drugId":"dienogest","brandName":"dienogest","genericName":"dienogest","approvalYear":"2010","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07496294","phase":"NA","title":"Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-04","conditions":["Menopausal Women","Menopausal Symptom Relief","Hormone Therapy","Menopausal Hormone Therapy"],"enrollment":200,"completionDate":"2027-10"},{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":["Progestins Primed Ovarian Stimulation"],"enrollment":626,"completionDate":"2026-09-30"},{"nctId":"NCT07358468","phase":"","title":"Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2026-02-22","conditions":["Infertility","Endometrial Peristalsis","Uterine Contraction","Endometrial Waves","Frozen Embryo Transfer (FET)","Uterine Peristalsis"],"enrollment":356,"completionDate":"2027-12-01"},{"nctId":"NCT07422506","phase":"NA","title":"A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-01-01","conditions":["Missed Abortion","Early Pregnancy Failure"],"enrollment":580,"completionDate":"2035-01-01"},{"nctId":"NCT07416578","phase":"NA","title":"Clinical Study on the Effect of Umbilical Cord Mesenchymal Stem Cell Exosomes on Endometrial Repair of Intrauterine Adhesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2026-01-01","conditions":["Intrauterine Adhesions","Exosomes"],"enrollment":60,"completionDate":"2026-12-31"},{"nctId":"NCT07409493","phase":"NA","title":"IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols","status":"RECRUITING","sponsor":"Hanoi Medical University","startDate":"2026-01-21","conditions":["Infertility (IVF Patients)","Embryo Morphokinetics","Progestins Primed Ovarian Stimulation"],"enrollment":148,"completionDate":"2028-10"},{"nctId":"NCT07409792","phase":"NA","title":"Multifaceted Benefits of Auricular Point Sticking for IVF Patients: Psychological Well-being, Sleep, and Treatment Outcomes","status":"ENROLLING_BY_INVITATION","sponsor":"Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University","startDate":"2025-08-31","conditions":["Infertility, Female","Anxiety","Assisted Reproductive Techniques","Dyssomnias","Depression"],"enrollment":178,"completionDate":"2026-12-31"},{"nctId":"NCT07348757","phase":"","title":"rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study","status":"RECRUITING","sponsor":"Centrum Clinic IVF Center","startDate":"2026-01-05","conditions":["InVitro Fertilization","Gonadotropins"],"enrollment":300,"completionDate":"2026-05-10"},{"nctId":"NCT07242131","phase":"NA","title":"Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS","status":"RECRUITING","sponsor":"Ege University","startDate":"2025-12-01","conditions":["Polycystic Ovary Syndrome (PCOS)"],"enrollment":150,"completionDate":"2026-06-01"},{"nctId":"NCT05847283","phase":"NA","title":"DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT","status":"RECRUITING","sponsor":"Tam Anh TP. Ho Chi Minh General Hospital","startDate":"2023-06-22","conditions":["Diminished Ovarian Reserve"],"enrollment":730,"completionDate":"2027-12-31"},{"nctId":"NCT07171970","phase":"NA","title":"IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2025-09-22","conditions":["Polycystic Ovary Syndrome (PCOS)","In Vitro Maturation of Oocytes","Fresh Embryo Transfer"],"enrollment":600,"completionDate":"2028-01-15"},{"nctId":"NCT07176143","phase":"NA","title":"hBMSC Uterine Artery Infusion for Severe IUA-Related Infertility","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-09-30","conditions":["Intrauterine Adhesions"],"enrollment":60,"completionDate":"2028-12-30"},{"nctId":"NCT06546397","phase":"PHASE1","title":"Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion","status":"RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2024-05-09","conditions":["Pregnancy Complications"],"enrollment":200,"completionDate":"2025-12-31"},{"nctId":"NCT03859921","phase":"PHASE3","title":"Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2021-07-01","conditions":["Subfertility"],"enrollment":716,"completionDate":"2026-11-30"},{"nctId":"NCT03680053","phase":"NA","title":"Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF","status":"TERMINATED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-04-10","conditions":["Infertility","ART"],"enrollment":220,"completionDate":"2025-05-10"},{"nctId":"NCT04414748","phase":"PHASE3","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-10","conditions":["Preimplantation Genetic Testing","Progestin-primed Ovarian Stimulation","Euploid Rate","GnRH Antagonist"],"enrollment":400,"completionDate":"2025-05-27"},{"nctId":"NCT03507673","phase":"","title":"Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2018-05-02","conditions":["Infertility"],"enrollment":1200,"completionDate":"2028-06-30"},{"nctId":"NCT04762316","phase":"PHASE4","title":"Composition for Treating Uterine Fibroid (SB-UF)","status":"COMPLETED","sponsor":"Trieu, Nguyen Thi, M.D.","startDate":"2019-01-01","conditions":["Uterine Fibroids Affecting Pregnancy"],"enrollment":66,"completionDate":"2021-02-01"},{"nctId":"NCT06952296","phase":"","title":"Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain","status":"NOT_YET_RECRUITING","sponsor":"Abbott","startDate":"2025-04","conditions":["Endometriosis"],"enrollment":250,"completionDate":"2026-06-30"},{"nctId":"NCT06868576","phase":"PHASE3","title":"PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2023-01-03","conditions":["PPOS","GnRH Antagonist","Assisted Reproductive Techniques"],"enrollment":328,"completionDate":"2025-02-28"},{"nctId":"NCT06812559","phase":"","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2023-12-01","conditions":["Controlled Ovarian Hyperstimulation","Polycystic Ovarian Syndrome"],"enrollment":100,"completionDate":"2025-02-01"},{"nctId":"NCT05767086","phase":"NA","title":"Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2023-03-15","conditions":["Infertility"],"enrollment":297,"completionDate":"2024-09-30"},{"nctId":"NCT06560814","phase":"PHASE2","title":"Non-surgical Interventions for Infertility in Endometriosis","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2020-07-01","conditions":["Endometriosis","Infertility, Female"],"enrollment":18,"completionDate":"2021-06-30"},{"nctId":"NCT05569577","phase":"NA","title":"An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients","status":"RECRUITING","sponsor":"Fudan University","startDate":"2021-01-01","conditions":["Luteal Phase Deficiency","Luteal Phase Support","Idiopathic Hypogonadotropic Hypogonadism"],"enrollment":46,"completionDate":"2025-12-31"},{"nctId":"NCT06396390","phase":"PHASE4","title":"Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nesta Clinic","startDate":"2024-08-01","conditions":["IVF","Fertility Issues","Infertility"],"enrollment":152,"completionDate":"2026-08-01"},{"nctId":"NCT04758871","phase":"PHASE4","title":"Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2021-10-01","conditions":["Frozen Embryo Transfer","Hormone Replacement Therapy","Dydrogesterone","Infertility, Female"],"enrollment":150,"completionDate":"2024-06-13"},{"nctId":"NCT03858049","phase":"PHASE4","title":"Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2019-05-31","conditions":["Infertility"],"enrollment":172,"completionDate":"2021-10-27"},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":["IVF"],"enrollment":240,"completionDate":"2024-02-20"},{"nctId":"NCT05168865","phase":"PHASE4","title":"Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.","status":"WITHDRAWN","sponsor":"Dubai Fertility Center","startDate":"2023-08-01","conditions":["Frozen Embryo Transfer","Polycystic Ovarian Disease","Letrozole","Hormone Replacement Therapy","Live Birth","Miscarriage"],"enrollment":0,"completionDate":"2024-04-01"},{"nctId":"NCT05521828","phase":"NA","title":"Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone","status":"UNKNOWN","sponsor":"CRG UZ Brussel","startDate":"2023-04-01","conditions":["Oocyte Donors","Oocyte Donation"],"enrollment":50,"completionDate":"2024-12-31"},{"nctId":"NCT05189145","phase":"NA","title":"Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2019-10-01","conditions":["Female Infertility"],"enrollment":600,"completionDate":"2021-10-01"},{"nctId":"NCT06212102","phase":"PHASE2","title":"Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation","status":"NOT_YET_RECRUITING","sponsor":"Bedaya Hospital","startDate":"2024-02","conditions":["Infertility"],"enrollment":120,"completionDate":"2026-12"},{"nctId":"NCT06191809","phase":"NA","title":"Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization","status":"UNKNOWN","sponsor":"Hanoi Medical University","startDate":"2023-02-14","conditions":["IVF"],"enrollment":200,"completionDate":"2024-12-31"},{"nctId":"NCT06132620","phase":"NA","title":"Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons","status":"COMPLETED","sponsor":"Yun Chen","startDate":"2017-04-01","conditions":["Menopause"],"enrollment":60,"completionDate":"2018-06-30"},{"nctId":"NCT05976529","phase":"","title":"A Multicenter, Observational Clinical Study of Dydrogesterone","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2023-01-01","conditions":["Endometriosis","Endometriosis Ovary"],"enrollment":400,"completionDate":"2025-12-31"},{"nctId":"NCT04414761","phase":"PHASE3","title":"Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-04","conditions":["IVF","GnRH Antagonist","PPOS"],"enrollment":784,"completionDate":"2022-10-10"},{"nctId":"NCT04788108","phase":"PHASE4","title":"Oral Progesterone for Prevention of Miscarriage in Threatened Abortion","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2021-08-01","conditions":["Threatened Abortion"],"enrollment":100,"completionDate":"2022-08-31"},{"nctId":"NCT05186779","phase":"","title":"Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy","status":"TERMINATED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2021-12-15","conditions":["Early Pregnancy Bleeding","Recurrent Pregnancy Loss"],"enrollment":50,"completionDate":"2023-07-14"},{"nctId":"NCT05951400","phase":"PHASE2,PHASE3","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist in With Expected High Ovarian Response Undergoing in Vitro Fertilization","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-08-20","conditions":["IVF","PCO"],"enrollment":200,"completionDate":"2023-09-30"},{"nctId":"NCT05972902","phase":"PHASE3","title":"Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-15","conditions":["IVF"],"enrollment":387,"completionDate":"2023-12-31"},{"nctId":"NCT03619707","phase":"PHASE4","title":"Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer Cycles","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2018-08-01","conditions":["Sterility","Infertility"],"enrollment":157,"completionDate":"2021-10-01"},{"nctId":"NCT05945407","phase":"NA","title":"Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2016-08-01","conditions":["Endometrial Neoplasms","Endometrial Neoplasm Malignant","Endometrial Neoplasm Malignant Stage I","Carcinoma, Endometrioid","Fertility Preservation"],"enrollment":57,"completionDate":"2027-12-31"},{"nctId":"NCT05939284","phase":"NA","title":"Progesterone-Primed Ovarian Simulation in Controlled-ovarian Simulation of Infertile PCOS Patients","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-06-01","conditions":["PCOS"],"enrollment":238,"completionDate":"2023-01-25"},{"nctId":"NCT05678192","phase":"PHASE1","title":"Effect of Menopausal Hormone Therapy on Immune System Parameters","status":"COMPLETED","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2021-12-01","conditions":["Last Period Not Earlier Than 6 Months Ago"],"enrollment":40,"completionDate":"2023-03-01"},{"nctId":"NCT05847660","phase":"NA","title":"Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient","status":"UNKNOWN","sponsor":"Fayoum University","startDate":"2023-06-01","conditions":["Polycystic Ovary Syndrome","Infertility","IVF"],"enrollment":210,"completionDate":"2024-07-01"},{"nctId":"NCT05758064","phase":"PHASE2,PHASE3","title":"The Rescue of Hormonal Replacement Frozen Embryo Transfer Cycle With Low Serum Progesterone.","status":"UNKNOWN","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2023-01-01","conditions":["Hormonal Replacement Frozen Embryo Transfer Cycle"],"enrollment":120,"completionDate":"2023-12-31"},{"nctId":"NCT05751681","phase":"NA","title":"Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2023-02-20","conditions":["Ovary Cyst","Fertility Issues"],"enrollment":79,"completionDate":"2025-03-20"},{"nctId":"NCT03675139","phase":"PHASE3","title":"MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia","status":"COMPLETED","sponsor":"Xiaojun Chen","startDate":"2019-02-26","conditions":["Endometrial Hyperplasia Without Atypia"],"enrollment":471,"completionDate":"2022-05-15"},{"nctId":"NCT05577806","phase":"","title":"DYG Versus Cetrorelix in Oocyte Donation","status":"COMPLETED","sponsor":"Clinica de la Mujer Medicina Reproductiva, Chile","startDate":"2017-01-01","conditions":["Infertility, Female","Fertility Disorders"],"enrollment":202,"completionDate":"2021-12-31"},{"nctId":"NCT03794037","phase":"PHASE2","title":"Montelukast for Prevention & Treatment of OHSS","status":"SUSPENDED","sponsor":"Benha University","startDate":"2018-12-05","conditions":["Ovarian Hyperstimulation Syndrome"],"enrollment":20,"completionDate":"2023-12"},{"nctId":"NCT05542797","phase":"PHASE4","title":"Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.","status":"UNKNOWN","sponsor":"Konya Meram State Hospital","startDate":"2022-10","conditions":["Miscarriage Threatening"],"enrollment":140,"completionDate":"2024-11"},{"nctId":"NCT05021094","phase":"PHASE4","title":"Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2021-10-22","conditions":["Primary Ovarian Insufficiency"],"enrollment":120,"completionDate":"2023-12-31"},{"nctId":"NCT05474703","phase":"","title":"Evaluation of the Effects of Levonorgestrel-releasing Intrauterine Device and Dydrogestreone on Quality of Life and Sexual Life in Patients With Abnormal Uterine Bleeding.","status":"UNKNOWN","sponsor":"Kanuni Sultan Suleyman Training and Research Hospital","startDate":"2022-02-20","conditions":["Abnormal Uterine Bleeding"],"enrollment":171,"completionDate":"2022-08-10"},{"nctId":"NCT05467852","phase":"PHASE3","title":"Didroxyprogesterone Promotes Natural Pregnancy in Infertile Patients With Endometriosis","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2022-12-10","conditions":["Pregnancy Rate"],"enrollment":300,"completionDate":"2025-12-10"},{"nctId":"NCT02921763","phase":"","title":"A Survey on Efficacy and Safety in Patients With Endometriosis","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2016-08-23","conditions":["Endometriosis"],"enrollment":60,"completionDate":"2017-10-13"},{"nctId":"NCT05437471","phase":"NA","title":"Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2020-01-01","conditions":["Miscarriage, Recurrent"],"enrollment":39,"completionDate":"2022-05-30"},{"nctId":"NCT04052607","phase":"NA","title":"Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles","status":"TERMINATED","sponsor":"Ibn Sina Hospital","startDate":"2019-09-10","conditions":["Infertility"],"enrollment":56,"completionDate":"2020-04-30"},{"nctId":"NCT05300841","phase":"EARLY_PHASE1","title":"The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients\"","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2022-05-01","conditions":["PCOS","ICSI"],"enrollment":500,"completionDate":"2023-05-01"},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":["Infertility, Female"],"enrollment":90,"completionDate":"2021-09-01"},{"nctId":"NCT03948022","phase":"PHASE4","title":"Luteal Support in Frozen-Thawed Embryo Transfer Cycles","status":"COMPLETED","sponsor":"Centrum Clinic IVF Center","startDate":"2021-06-30","conditions":["Implantation; Placenta","Pregnancy Loss","Frozen Embryo","Luteal Support","Luteal Phase Defect","Assisted Reproduction"],"enrollment":151,"completionDate":"2021-12-20"},{"nctId":"NCT05156814","phase":"PHASE4","title":"Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women","status":"UNKNOWN","sponsor":"Scientific Research Institute of Public Health, Russian Federation","startDate":"2021-11-29","conditions":["Perimenopausal Disorder","Hot Flashes"],"enrollment":150,"completionDate":"2023-05"},{"nctId":"NCT03690765","phase":"","title":"Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis","status":"COMPLETED","sponsor":"Abbott","startDate":"2018-09-27","conditions":["Endometriosis"],"enrollment":350,"completionDate":"2020-05-29"},{"nctId":"NCT04249297","phase":"","title":"Predictors of Pregnancy Rate in Assisted Reproductive Technology According to Actual Guidelines","status":"UNKNOWN","sponsor":"Abbott","startDate":"2020-03-03","conditions":["Infertility"],"enrollment":1150,"completionDate":"2022-12"},{"nctId":"NCT05135013","phase":"","title":"The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study","status":"UNKNOWN","sponsor":"NewGiza University","startDate":"2021-11-16","conditions":["Observational Study"],"enrollment":200,"completionDate":"2022-03-31"},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":["PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries"],"enrollment":200,"completionDate":"2023-12"},{"nctId":"NCT04408144","phase":"NA","title":"Addition of Dydrogesterone to the Luteal Phase Support After Fresh Embryo Transfer","status":"UNKNOWN","sponsor":"Laniado Hospital","startDate":"2022-04-01","conditions":["Infertility","IVF"],"enrollment":300,"completionDate":"2023-05-31"},{"nctId":"NCT04972032","phase":"NA","title":"Efficacy of Estrogen-intrauterine Stent System After Intrauterine Adhesiolysis","status":"UNKNOWN","sponsor":"Limin Feng","startDate":"2020-09-02","conditions":["Intrauterine Adhesion"],"enrollment":246,"completionDate":"2025-03"},{"nctId":"NCT03620929","phase":"PHASE4","title":"Estrogen in the Prevention of Adhesion Reformation","status":"UNKNOWN","sponsor":"Fu Xing Hospital, Capital Medical University","startDate":"2018-08-13","conditions":["Asherman Syndrome"],"enrollment":186,"completionDate":"2022-12-01"},{"nctId":"NCT03998761","phase":"NA","title":"Progesterone Versus Progesterone Plus Dydrogesterone in FET","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2019-06-26","conditions":["Infertility"],"enrollment":1364,"completionDate":"2021-01-31"},{"nctId":"NCT03935152","phase":"PHASE4","title":"Oral Dydrogesterone in the Management of Preterm Labor","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2019-05-11","conditions":["Preterm Labor"],"enrollment":48,"completionDate":"2020-05-31"},{"nctId":"NCT03677336","phase":"PHASE4","title":"Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-05-01","conditions":["Infertility, Female","Infertility","Genital Diseases, Male","Genital Diseases, Female","Progesterone","Dydrogesterone","Hormones","Hormones, Hormone Substitutes, and Hormone Antagonists","Physiological Effects of Drugs","Progestins"],"enrollment":30,"completionDate":"2020-08-24"},{"nctId":"NCT03832699","phase":"NA","title":"Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer","status":"UNKNOWN","sponsor":"Wolfson Medical Center","startDate":"2019-03-01","conditions":["ART"],"enrollment":100,"completionDate":"2021-10"},{"nctId":"NCT04287205","phase":"NA","title":"The Effect of Dydrogesterone on Sexual Function in Women With Endometriosis","status":"COMPLETED","sponsor":"Kanuni Sultan Suleyman Training and Research Hospital","startDate":"2019-04-20","conditions":["Endometriosis","Sexual Dysfunction"],"enrollment":79,"completionDate":"2020-03-03"},{"nctId":"NCT03790215","phase":"PHASE4","title":"Dydrogesterone in the Treatment of Endometrial Polyps","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2019-02-01","conditions":["Endometrial Polyp"],"enrollment":60,"completionDate":"2019-12-31"},{"nctId":"NCT04175990","phase":"PHASE1","title":"IVF Outcome Following Progestogen Ovarian Stimulation","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2018-05-10","conditions":["IVF","Oocyte Maturation Defect 1","Clinical Pregnancy Rate","Ovarian Hyperstimulation"],"enrollment":155,"completionDate":"2019-05-09"},{"nctId":"NCT04124913","phase":"PHASE4","title":"Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Memorial Sisli Hospital, Istanbul","startDate":"2019-01-02","conditions":["Infertility, Female","Infertility, Male","Embryo Transfer","Fertilization in Vitro","Drug Effect","Reproductive Techniques, Assisted","Progesterone","Dydrogesterone"],"enrollment":140,"completionDate":"2019-12"},{"nctId":"NCT02491437","phase":"PHASE3","title":"A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)","status":"COMPLETED","sponsor":"Abbott","startDate":"2015-07","conditions":["Female Infertility"],"enrollment":1034,"completionDate":"2017-05"},{"nctId":"NCT03428685","phase":"PHASE2,PHASE3","title":"Progesterone to Prevent Preterm Delivery","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2019-01-15","conditions":["Preterm Birth"],"enrollment":1714,"completionDate":"2023-01"},{"nctId":"NCT03773263","phase":"PHASE3","title":"New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2018-12","conditions":["Polycystic Ovary Syndrome","Infertility"],"enrollment":300,"completionDate":"2020-03"},{"nctId":"NCT02128685","phase":"PHASE3","title":"Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2016-03","conditions":["Pregnancy"],"enrollment":406,"completionDate":"2018-05-31"},{"nctId":"NCT03537287","phase":"PHASE2","title":"Different Types of Progesterone in the Prevention of Preterm Labor","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2016-07","conditions":["Preterm Labor"],"enrollment":140,"completionDate":"2018-08"},{"nctId":"NCT03456570","phase":"EARLY_PHASE1","title":"The Efficacy of Progestins in Treatment of Functional Ovarian Cyst","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-05-01","conditions":["Functional Ovarian Cyst","Progesterone"],"enrollment":90,"completionDate":"2020-09-01"},{"nctId":"NCT03436303","phase":"PHASE4","title":"The Benefits and Risks of Different Menopausal Hormone Replacement Therapy Regimes in the Treatment of Menopause Syndrome","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2014-02-01","conditions":["Menopause Syndrome"],"enrollment":120,"completionDate":"2018-12-01"},{"nctId":"NCT03309735","phase":"","title":"Non-interventional Study of Therapy for Threatened Miscarriage","status":"COMPLETED","sponsor":"Besins Healthcare","startDate":"2017-10-16","conditions":["Threatened Miscarriage"],"enrollment":1241,"completionDate":"2017-12-22"},{"nctId":"NCT01850030","phase":"PHASE3","title":"A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization","status":"COMPLETED","sponsor":"Abbott","startDate":"2013-08","conditions":["Female Infertility"],"enrollment":1070,"completionDate":"2016-03"},{"nctId":"NCT03351205","phase":"NA","title":"The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis","status":"UNKNOWN","sponsor":"Beijing Obstetrics and Gynecology Hospital","startDate":"2017-11-21","conditions":["Intrauterine Adhesion"],"enrollment":100,"completionDate":"2018-11-22"},{"nctId":"NCT03346317","phase":"NA","title":"Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis","status":"UNKNOWN","sponsor":"Beijing Obstetrics and Gynecology Hospital","startDate":"2017-11-16","conditions":["Intrauterine Adhesion"],"enrollment":100,"completionDate":"2018-05-20"},{"nctId":"NCT03329898","phase":"NA","title":"Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion","status":"UNKNOWN","sponsor":"Beijing Obstetrics and Gynecology Hospital","startDate":"2017-10-31","conditions":["Intrauterine Adhesion"],"enrollment":200,"completionDate":"2018-11-25"},{"nctId":"NCT02989519","phase":"PHASE3","title":"Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor","status":"COMPLETED","sponsor":"Sanpasitthiprasong Hospital","startDate":"2015-08","conditions":["Preterm Delivery"],"enrollment":231,"completionDate":"2017-03-01"},{"nctId":"NCT03267771","phase":"PHASE4","title":"Progesterone and Doppler in Recurrent Abortion","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-10-01","conditions":["Abortion in First Trimester"],"enrollment":50,"completionDate":"2019-12-05"},{"nctId":"NCT02086032","phase":"NA","title":"The Effect of Different Types of Progestin on Sleeping of Menopausal Women","status":"COMPLETED","sponsor":"Chiang Mai University","startDate":"2014-01","conditions":["Menopausal and Postmenopausal Disorders"],"enrollment":100,"completionDate":"2015-07"},{"nctId":"NCT02726971","phase":"PHASE1,PHASE2","title":"Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion","status":"COMPLETED","sponsor":"Fu Xing Hospital, Capital Medical University","startDate":"2016-04","conditions":["Asherman Syndrome"],"enrollment":141,"completionDate":"2016-08"},{"nctId":"NCT02990403","phase":"PHASE4","title":"The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss","status":"UNKNOWN","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2014-10","conditions":["Recurrent Pregnancy Loss"],"enrollment":500,"completionDate":"2018-12-22"},{"nctId":"NCT02706470","phase":"PHASE2,PHASE3","title":"Use of Cyclosporin A for the Treatment of Recurrent Miscarriage","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2016-05","conditions":["Miscarriage, Recurrent"],"enrollment":384,"completionDate":"2018-12"},{"nctId":"NCT02262481","phase":"NA","title":"Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2014-08","conditions":["Preterm Labor"],"enrollment":48,"completionDate":"2015-06"},{"nctId":"NCT01711216","phase":"","title":"Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan","status":"COMPLETED","sponsor":"Abbott","startDate":"2012-08","conditions":["Irregular Menstrual Cycle"],"enrollment":999,"completionDate":"2014-08"},{"nctId":"NCT02620345","phase":"PHASE4","title":"Fibroids in Women of Reproductive Age and Women Pregnancy","status":"COMPLETED","sponsor":"Trieu, Nguyen Thi, M.D.","startDate":"2010-01","conditions":["Fibroids"],"enrollment":22,"completionDate":"2015-11"},{"nctId":"NCT02496052","phase":"NA","title":"The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions","status":"UNKNOWN","sponsor":"Beijing Obstetrics and Gynecology Hospital","startDate":"2013-01","conditions":["Intrauterine Adhesions"],"enrollment":300,"completionDate":"2017-06"},{"nctId":"NCT02029144","phase":"","title":"Observational Study of Dydrogesterone in Cycle Regularization","status":"COMPLETED","sponsor":"Fudan University","startDate":"2013-12","conditions":["Observational Study","Dydrogesterone","Irregular Menstrual Cycle","Abnormal Uterine Bleeding"],"enrollment":114,"completionDate":"2015-02"},{"nctId":"NCT01525563","phase":"","title":"Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study","status":"COMPLETED","sponsor":"Abbott","startDate":"2012-04","conditions":["Irregular Menstrual Cycle"],"enrollment":1000,"completionDate":"2013-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000167428","NDDF":"001296","UNII":"90I02KLE8K","CHEBI":"CHEBI:31527","INN_ID":"970","RXNORM":"3706","UMLSCUI":"C0013340","chemblId":"CHEMBL1200853","ChEMBL_ID":"CHEMBL1200853","KEGG_DRUG":"D01217","DRUGBANK_ID":"DB00378","PUBCHEM_CID":"9051","SNOMEDCT_US":"126093005","IUPHAR_LIGAND_ID":"2878","MESH_DESCRIPTOR_UI":"D004394"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Solvay","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"28%"},"publicationCount":802,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"G03DB01","allCodes":["G03DB01","G03FA14","G03FB08"]},"biosimilarFilings":[],"originalDeveloper":"Solvay","recentPublications":[],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"Solvay","companyId":"solvay","modality":"Small molecule","firstApprovalDate":"1982","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"1965-12-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"SOLVAY","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"SOLVAY","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":"SOLVAY","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":null,"mah":"SOLVAY","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"SOLVAY","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":"SOLVAY","brand_name_local":null,"application_number":null},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":4,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:42:27.185883+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}